Human gene therapy methods Impact Factor in Biotechnology

Human gene therapy methods in Biotechnology

Journal Country: United States
Journal Q tier: Q2
Publishing Firm: Mary Ann Liebert Inc.
History: 2012-2019
Journal Homepage: ----
Journal ISSN: 19466536, 19466544

Research Categories

Applied Microbiology and Biotechnology (Q2); Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (clinical) (Q3)

Impact Score: 0
h-Index: 35
SJR: 0.78
Ranking: 6182

About Human gene therapy methods

Human gene therapy methods is a journal covering the technologies/fields/categories related to Applied Microbiology and Biotechnology (Q2); Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (clinical) (Q3). It is published by Mary Ann Liebert Inc.. The overall rank of Human gene therapy methods is 6182.According to SCImago Journal Rank (SJR), this journal is ranked 0.780. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 35. The best quartile for this journal is Q2.The ISSN of Human gene therapy methods journal is 19466536, 19466544.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Human gene therapy methods is cited by a total of 88 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.